KAPOOR JOHN N 4

Accession 0001171843-18-000700

CIK 0000003116other

View on SEC.gov Company Profile

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 6:00 PM ET

Size

20.0 KB

Accession

0001171843-18-000700

Insider Transaction Report

Form 4

Period: 2018-01-25

AKORN INCAKRX

KAPOOR JOHN N

Director10% Owner

Transactions

Exercise/Conversion
Stock Options (Right to Buy)
2018-01-25−10,753→ 0 total
Exercise: $24.74From: 2015-05-02→ Common Stock (10,753 underlying)
Exercise/Conversion
Common Stock
2018-01-25$24.74/sh+10,753$266,029→ 513,814 total
Sale
Common Stock
2018-01-25$32.67/sh−13,629$445,259→ 505,987 total
Exercise/Conversion
Common Stock
2018-01-25$29.50/sh+5,802$171,159→ 519,616 total
Exercise/Conversion
Stock Options (Right to Buy)
2018-01-25−5,802→ 0 total
Exercise: $29.50→ Common Stock (5,802 underlying)

Holdings

Common Stock
(indirect: By Partnership)
2,970,644
Common Stock
(indirect: By Partnership)
15,050,000
Common Stock
(indirect: By Trust)
1,907,445
Common Stock
(indirect: By Partnership)
3,590,445
Common Stock
(indirect: By Trust)
4,427,462

Akorn Holdings, L.P.

10% Owner

Transactions

Exercise/Conversion
Common Stock
2018-01-25$29.50/sh+5,802$171,159→ 519,616 total
Exercise/Conversion
Stock Options (Right to Buy)
2018-01-25−5,802→ 0 total
Exercise: $29.50→ Common Stock (5,802 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2018-01-25−10,753→ 0 total
Exercise: $24.74From: 2015-05-02→ Common Stock (10,753 underlying)
Sale
Common Stock
2018-01-25$32.67/sh−13,629$445,259→ 505,987 total
Exercise/Conversion
Common Stock
2018-01-25$24.74/sh+10,753$266,029→ 513,814 total

Holdings

Common Stock
(indirect: By Partnership)
15,050,000
Common Stock
(indirect: By Partnership)
3,590,445
Common Stock
(indirect: By Partnership)
2,970,644
Common Stock
(indirect: By Trust)
4,427,462
Common Stock
(indirect: By Trust)
1,907,445

Footnotes (11)

[F1]The Reporting Person exercised these stock options in advance of their new expiration date of January 30, 2018, which date is three months following the Reporting Person's resignation from the Company's board of directors.
[F10]The Stock Options that were exercised vested in two tranches: 2,901 options vested on July 1, 2016, and 2,901 options vested on July 1, 2017. Upon resignation from the Company's board of directors, the Reporting Person forfeited two additional tranches of 2,900 options each that were scheduled to vest on July 1, 2018 and July 1, 2019.
[F11]The original expiration date of these stock options was July 1, 2023. Upon the Reporting Person's resignation from the Company's board of directors, the expiration date was accelerated to January 30, 2018, which is three months after the Reporting Person's resignation date.
[F2]The securities owned by the Reporting Person following the reported transaction reflect the forfeiture of 10,418 Restricted Stock Units (RSUs) that were forfeited upon the Reporting Person's resignation from the Company's board of directors on October 30, 2017.
[F3]The Reporting Person sold shares to cover the exercise price of the options exercised.
[F4]Represents the weighted average sale price of the shares sold. The shares were sold at prices ranging from $32.58 to $32.71. Upon request, the Reporting Person will provide to the SEC staff full information regarding the number of shares sold at separate prices within the foregoing range.
[F5]Shares held by Akorn Holdings, L.P., a Delaware limited partnership, of which Dr. Kapoor is the indirect managing general partner. Dr. Kapoor disclaims beneficial ownership of such shares except to the extent of his actual pecuniary interest therein.
[F6]Shares held through several trusts, the trustee of which is employed by a company controlled by Dr. Kapoor and the beneficiaries of which include Dr. Kapoor's children and various other family members. Dr. Kapoor disclaims beneficial ownership of such shares except to the extent of his actual pecuniary interest therein.
[F7]Shares held by a limited partnership of which Dr. Kapoor is the indirect managing general partner. Dr. Kapoor disclaims beneficial ownership of such shares except to the extent of his actual pecuniary interest therein.
[F8]Shares held by a trust of which Dr. Kapoor is sole trustee and beneficiary.
[F9]The original expiration date of these stock options was May 2, 2019. Upon the Reporting Person's resignation from the Company's board of directors, the expiration date was accelerated to January 30, 2018, which is three months after the Reporting Person's resignation date.

Documents

1 file

4
form4kapoor.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

AKORN INC

CIK 0000003116

→

Entity typeother

Related Parties

filerCIK 0001033150

Filing Metadata

Form type: 4
Filed: Jan 25, 7:00 PM ET
Accepted: Jan 26, 6:00 PM ET
Size: 20.0 KB

View on SEC.gov